Manipal Health Enterprises has fixed the price band for its initial public offering at ₹560 to ₹590 per share, setting the stage for a public debut later this month.
The pricing decision crystallizes the valuation framework for the healthcare operator, which is preparing to list on Indian exchanges.
The move follows reports that the operator was targeting a valuation of approximately ₹80,000 crore ($8.
The issue is scheduled to open for subscription in the week beginning July 27.
By locking in the price range, the company provides clarity to institutional and retail investors on the entry point for the offering.
The move follows reports that the operator was targeting a valuation of approximately ₹80,000 crore ($8.3 billion), reflecting a recalibrated stance amid broader market dynamics.
Backed by Singapore’s Temasek Holdings, Manipal Health Enterprises is positioning itself as a major player in India’s private healthcare sector.